Results 101 to 110 of about 6,136 (180)

Altered expression of neuroplasticity-related genes in the brain of depressed suicides [PDF]

open access: yes, 2015
Background: Expression of the neuronal membrane glycoprotein M6a (GPM6A), the proteolipid protein (PLP/DM20) family member, is downregulated in the hippocampus of chronically stressed animals.
Alvarez Juliá, Anabel   +4 more
core   +1 more source

Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system

open access: yesNeurobiology of Disease, 2007
Myelin degeneration in the central nervous system (CNS) is often associated with elevated numbers of T cells in brain and spinal cord (SC). In some degenerative diseases, this T cell immigration has no clinical relevance, in others, it may precede severe
Roland Grundtner   +13 more
doaj   +1 more source

Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis. [PDF]

open access: yes, 2019
CXCR2 is a chemokine receptor expressed on oligodendroglia that has been implicated in the pathogenesis of neuroinflammatory demyelinating diseases as well as enhancement of the migration, proliferation, and myelin production by oligodendroglia. Using an
Cheng, Yuting   +9 more
core   +1 more source

Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. [PDF]

open access: yes, 2019
BACKGROUND:Retinal optical coherence tomography (OCT) is a clinical and research tool in multiple sclerosis, where it has shown significant retinal nerve fiber (RNFL) and ganglion cell (RGC) layer thinning, while postmortem studies have reported RGC loss.
Aktas, Orhan   +18 more
core   +1 more source

Relapsing-remitting multiple sclerosis: advances in disease-modifying therapies [PDF]

open access: yes, 2015
Multiple sclerosis is a demyelinating disease affecting the central nervous system. It is the most prevalent disabling neurological condition among young adults, with onset typically between 20 and 40 years of age. Infiltrating immune cells and microglia
Kay, Kathleen Alexandra
core   +1 more source

Identification And Characterization Of A Second Encephalitogenic Determinant Of Myelin Proteolipid Protein (Residues 178-191) For SJL Mice [PDF]

open access: yes, 1992
We previously described a synthetic peptide of myelin proteolipid protein (PLP), peptide 139-151, which induces experimental allergic encephalomyelitis in SJL/J (H-2s) mice.
Greer, J. M.   +3 more
core  

High resolution neurochemical gold staining method for myelin in peripheral and central nervous system at the light- and electron-microscopic level [PDF]

open access: yes, 2018
Myelin is a multilamellar membrane structure primarily composed of lipids and myelin proteins essential for proper neuronal function. Since myelin is a target structure involved in many pathophysiological conditions such as metabolic, viral, and ...
Eyupoglu, Ilker   +3 more
core  

Regulation of T cell responses by Heme Oxygenase-1 [PDF]

open access: yes, 2008
Tese de mestrado, Biologia (Biologia Molecular e Genética), 2008, Universidade de Lisboa, Faculdade de CiênciasMultiple sclerosis (MS) is a chronic inflammatory disease that affects the central nervous system (CNS).
Cortez, Eliane Cristina Monteiro
core  

Effect of High Intensity Exercise Preconditioning on the Prevention of Myelin damage in Hippocampus of Male C57BL/6 Mice

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2019
Introduction: Multiple sclerosis (MS) is a common neurodegenerative disease leading to the movement disorder and destruction of myelin. Physical exercise delays the onset of neurodegenerative processes by preventing the destruction of myelin and ...
Maryam Naghibzadeh   +3 more
doaj   +2 more sources

Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis. [PDF]

open access: yes, 2013
BackgroundTherapeutic strategies that induce effective neuroprotection and enhance intrinsic repair mechanisms are central goals for future treatment of multiple sclerosis (MS), as well as other diseases.
Hannsun, Gemmy   +9 more
core  

Home - About - Disclaimer - Privacy